Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE).
about
The non-canonical NF-κB pathway in immunity and inflammation.Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.Testosterone is an endogenous regulator of BAFF and splenic B cell number.New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis
P2860
Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Inhibition of B cell activatin ...... mic lupus erythematosus (SLE).
@ast
Inhibition of B cell activatin ...... mic lupus erythematosus (SLE).
@en
type
label
Inhibition of B cell activatin ...... mic lupus erythematosus (SLE).
@ast
Inhibition of B cell activatin ...... mic lupus erythematosus (SLE).
@en
prefLabel
Inhibition of B cell activatin ...... mic lupus erythematosus (SLE).
@ast
Inhibition of B cell activatin ...... mic lupus erythematosus (SLE).
@en
P2860
P1476
Inhibition of B cell activatin ...... mic lupus erythematosus (SLE).
@en
P2093
William Stohl
P2860
P304
P356
10.1080/1744666X.2017.1291343
P577
2017-02-04T00:00:00Z